• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: Ascletis BioScience Co. Ltd.

Biotech IPO rain dance continues and not just in the USA. My take on where to place your bets.

Steve Walker    May 15, 2018 May 15, 2018    No Comments on Biotech IPO rain dance continues and not just in the USA. My take on where to place your bets.

It’s been said that biotechs are among the riskiest of initial public offerings due to the dualistic nature of their meds: they either succeed or they flop. There’s usually no… Read more »

Corporate, Investment, Pharmaceuticals    Abpro Inc., AnaptysBio, Ascletis BioScience Co. Ltd., AveXis Inc., CRO WuXi AppTec, Denali Therapeutics, Endpoints, Evelo Biosciences Inc., Ganovo, Homology Medicines Inc., IPO, Loxo Oncology Inc., Renaissance Capital, Scholar Rock Inc., Solid Biosciences Inc., Unity Biotechnology Inc.

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • Healthcare stocks keep rockin as February begins with searing action. Will it last, or flame out?
  • Healthcare IPOs keep rolling along, and not just in the US. Will March come in like a lion, or a...
  • Insys trial opens with tale of sales rep giving lap dance to doctor for fentanyl prescriptions. News organizations seize upon...
  • Three healthcare stocks shine while two fizzle to cap the first month of 2019’s investor lottery. Who’s a rational bet...
    • Elizabeth Holmes and Mark Zuckerberg: The rise and fall of the black turtleneck, hoodie and jeans. Op Ed
    • Unknown Kentucky biotech Bexion tests new glioma med on first patients. Yes, it’s the same cancer Sen. McCain is fighting,...
    • Biotech IPOs rock in 2018. More are storming into the queue.
    • Apitope moves Graves’ disease candidate toward Phase 2; a primer on autoimmune disease “for people in a hurry.”
    Copyright 2018
    Ribosome by GalussoThemes.com
    Powered by WordPress